基础医学与临床 ›› 2024, Vol. 44 ›› Issue (3): 389-392.doi: 10.16352/j.issn.1001-6325.2024.03.0389

• 短篇综述 • 上一篇    下一篇

P2X7受体在癌痛中作用的研究进展

张忠文1, 赵瑞2, 张浩龙3, 杨钰婷4, 白金霞4, 张浩令3*, 王薇4*   

  1. 甘肃中医药大学 1.公共卫生学院;2.中医临床学院;4.针灸推拿学院,甘肃 兰州 730000;
    3.马来西亚理科大学 高级医学与牙科研究所,马来西亚 槟城 13200
  • 收稿日期:2023-06-07 修回日期:2023-12-01 出版日期:2024-03-05 发布日期:2024-02-22
  • 通讯作者: *:wangwei@gszy.edu.cn;zhanghaolingedu@163.com
  • 基金资助:
    甘肃省自然科学基金(22JR5RA582,21JR1RA267);甘肃省高等学校创新基金(2023A-088);甘肃省中医药研究中心专项开放课题(zyzx-2020-zx10);甘肃省教育科技创新项目(2022A-067)

Research progress on P2X7 receptor in cancer pain

ZHANG Zhongwen1, ZHAO Rui2, ZHANG Haolong3, YANG Yuting4, BAI Jinxia4, ZHANG Haoling3* WANG Wei*   

  1. 1. School of Public Health; 2. Clinical College of Chinese Medicine; 4. College of Acupuncture-Moxibustion and Tuing, Gansu University of Chinese Medicine, Lanzhou 730000, China;
    3. Advanced Medical and Dental Institute, University Sains Malaysia,Penang 13200, Malaysia
  • Received:2023-06-07 Revised:2023-12-01 Online:2024-03-05 Published:2024-02-22
  • Contact: *:wangwei@gszy.edu.cn;zhanghaolingedu@163.com

摘要: P2X7受体是一种ATP门控离子通道,在肿瘤条件下,P2X7受体的激活触发了促炎细胞因子的释放,刺激了伤害性神经元的兴奋,从而加剧了疼痛的传递。在临床前癌疼痛模型中,具有作为癌疼痛管理的新治疗靶点的潜力。

关键词: P2X7受体, 癌痛, 神经胶质细胞, P2X7拮抗剂

Abstract: The activation of the P2X7 receptor as an ATP-gated ion channel, triggers the release of pro-inflammatory cytokines in tumor carring individuals and stimulate excitation of injury-causing neurons, thereby exacerbating the transmission of pain. In preclinical cancer pain models, it has the potential to serve as a new therapeutic target for cancer pain management.

Key words: P2X7 receptor, cancer pain, glial cell, P2X7 antagonist

中图分类号: